NCT02393339

Brief Summary

The aim of the study is to compare the efficacy of the pre-operative administration of Paracetamol and placebo in reducing postoperative pain after routine dental treatment in children. This study will be a prospective, placebo-controlled, randomized, double-blind trial. Patients in need of dental treatment with local anesthesia will take part in the study. Study group will receive syrup paracetamol 15 min before the dental treatment. Control group will receive placebo syrup, similar in color and viscosity, 15 min before dental treatment. the patient, the treating dentist, and the interviewer will be blind to the medication. Main outcome measure: one of the main investigators will interview the patient at three time points: immediately at the end of the treatment, one hour after taking the pre-operative analgesic and by phone 2.5 hours after taking the pre-operative analgesic. The patient and his parents will be asked if the child is crying (yes/no), complaining about pain (yes/no), needed a different kind of analgesics after the treatment (yes/no). In addition, each child will describe his ⁄ her feelings regarding postoperative pain, using the Wong-Baker Facial Rating Pain Scale

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
114

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Feb 2017

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 9, 2015

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 19, 2015

Completed
1.9 years until next milestone

Study Start

First participant enrolled

February 1, 2017

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2020

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

March 3, 2021

Completed
Last Updated

March 3, 2021

Status Verified

March 1, 2021

Enrollment Period

2.9 years

First QC Date

March 9, 2015

Results QC Date

February 9, 2021

Last Update Submit

March 2, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain, as Measured by Wong-Baker Facial Rating Pain Scale ,After Routine Dental Treatment

    This scale measures the unpleasantness or effective dimension of a child's pain experience. The child is shown a set of six cartoon faces with varying facial expressions from smile\\laughter to tears. Each face has a numerical value, from 0 (smiling face) to 5 (tears). The child selects the facial expression that best represents his \\her experience of discomfort.

    2.5 hours after taking the pre-operative analgesic.

Study Arms (2)

study group

ACTIVE COMPARATOR

Study group will receive syrup paracetamol (15 mg/kg) 15 min before the dental treatment

Drug: paracetamol

controll group

PLACEBO COMPARATOR

Control group will receive placebo syrup, designed to mimic paracetamol syrup, similar in color and viscosity, 15 min before dental treatment.

Drug: placebo

Interventions

Pre-operative administration of Paracetamol syrup

Also known as: acetaminophen
study group

Pre-operative administration of placebo syrup

controll group

Eligibility Criteria

Age5 Years - 12 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • healthy
  • in need of dental treatment with local anesthesia

You may not qualify if:

  • preoperative pain,
  • patients taking analgesics within 5 h prior to the dental treatment
  • allergic reaction or adverse effect to paracetamol
  • not available (by phone) at least 2 hours after treatment
  • patient refuse to drink the syrup
  • dental treatment without local anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hadassah Medical Organization

Jerusalem, 91120, Israel

Location

MeSH Terms

Conditions

Pain, PostoperativeAgnosia

Interventions

Acetaminophen

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and SymptomsPerceptual DisordersNeurobehavioral ManifestationsNervous System Diseases

Intervention Hierarchy (Ancestors)

AcetanilidesAnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Results Point of Contact

Title
Dr. Avia Fux-Noy
Organization
Hadassah School of Dental Medicine, P.O.Box 12272

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
pediatric dentist

Study Record Dates

First Submitted

March 9, 2015

First Posted

March 19, 2015

Study Start

February 1, 2017

Primary Completion

January 1, 2020

Study Completion

January 31, 2020

Last Updated

March 3, 2021

Results First Posted

March 3, 2021

Record last verified: 2021-03

Locations